In treating human breast cancer cells, calycosin (0.5–100 μM) diminished Akt phosphorylation and reduced PI3K/Akt pathway activation, which results in the downregulation of HOTAIR expression, leading to control proliferation, invasion, and migration and inhibits apoptosis.59 This evidence concerns the gene AKT1 and breast cancer.